首页 › 基金 › Samsara BioCapital, LLC › SRRK
Samsara BioCapital, LLC 对 SRRK 的持仓历史
SCHOLAR ROCK HLDG CORP · 医疗保健
Samsara BioCapital, LLC 在 Q3 2026 的 13F 申报中披露持有 SRRK(SCHOLAR ROCK HLDG CORP)6,897,652 股,市值约 US$333.3M,约占其申报组合的 31.69%,在其申报持仓中市值排名第 1 位。 Samsara BioCapital, LLC 最近 13 个申报季度中有 13 个季度披露了 SRRK 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR
Samsara BioCapital, LLC 对 SRRK 的持仓演变
Samsara BioCapital, LLC 于 Q3 2023 首次披露 SRRK 持仓:4,598,828 股(约 US$32.7M)。 该持仓在 Q2 2026 达到峰值 6,897,652 股,市值约 US$379.4M。 在 13 次申报中,Samsara BioCapital, LLC 2 次增持、1 次减持、9 次保持不变。 最近一期申报(Q3 2026)显示持股 6,897,652 股、市值约 US$333.3M。 持仓曾出现大幅变动:Q4 2023 增持约 48% (随后一个季度股价下跌 6%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 4.60M | $32.65M | 新进 |
| Q4 2023 | 6.79M | $127.63M | 增持 |
| Q1 2024 | 6.79M | $120.57M | 持有 |
| Q2 2024 | 6.79M | $56.55M | 持有 |
| Q3 2024 | 6.79M | $54.38M | 持有 |
| Q4 2024 | 5.61M | $242.59M | 减持 |
| Q1 2025 | 5.61M | $180.45M | 持有 |
| Q2 2025 | 5.61M | $198.81M | 持有 |
| Q3 2025 | 5.61M | $209.02M | 持有 |
| Q4 2025 | 6.90M | $303.84M | 增持 |
| Q1 2026 | 6.90M | $339.09M | 持有 |
| Q2 2026 | 6.90M | $379.37M | 持有 |
| Q3 2026 | 6.90M | $333.29M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 SRRK 与 13F 数据
SRRK(SCHOLAR ROCK HLDG CORP)属于医疗保健行业。我们追踪的基金中还有 46 只申报持有 SRRK,申报仓位最大的包括:Siren, L.L.C. (US$453.0M), Orbis Allan Gray Ltd (US$293.6M), Redmile Group, LLC (US$146.6M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 SRRK 的基金
- Siren, L.L.C. 9.38M 股 · $453.00M · Q3 2026
- Orbis Allan Gray Ltd 6.08M 股 · $293.56M · Q3 2026
- Redmile Group, LLC 3.03M 股 · $146.60M · Q3 2026
- Bellevue Group AG 2.79M 股 · $134.66M · Q3 2026
- ARCH Venture Management, LLC 2.35M 股 · $113.34M · Q3 2026
- DRIEHAUS CAPITAL MANAGEMENT LLC 2.32M 股 · $112.13M · Q3 2026
- Hood River Capital Management LLC 2.25M 股 · $108.81M · Q3 2026
- EVENTIDE ASSET MANAGEMENT, LLC 2.08M 股 · $100.40M · Q3 2026
- Integral Health Asset Management, LLC 1.25M 股 · $60.64M · Q3 2026
- Casdin 资本 850.00K 股 · $41.07M · Q3 2026
更多关于 Samsara BioCapital, LLC
常见问题
How long has Samsara BioCapital, LLC held SRRK?
Samsara BioCapital, LLC has disclosed SRRK holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Samsara BioCapital, LLC's current position in SRRK?
As of Q3 2026, Samsara BioCapital, LLC holds 6.90M shares of SRRK (SCHOLAR ROCK HLDG CORP), valued at $333.29M, representing 31.69% of its reported portfolio and ranking #1.
Has Samsara BioCapital, LLC been buying or selling SRRK?
In the latest 13F filing (Q3 2026), Samsara BioCapital, LLC held unchanged its position in SRRK. The position peaked in Q2 2026 at 6.90M shares.
Which other funds hold SRRK?
Other major institutional holders of SRRK include Siren, L.L.C., Orbis Allan Gray Ltd, Redmile Group, LLC, among 46 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.